Literature DB >> 5134056

Use of sodium cephalothin in the management of lung gangrene.

B T le Roux.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1971        PMID: 5134056      PMCID: PMC472346          DOI: 10.1136/thx.26.5.551

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  PENICILLINASE-RESISTANT PENICILLINS AND CEPHALOSPORINS.

Authors:  M BARBER; P M WATERWORTH
Journal:  Br Med J       Date:  1964-08-08

2.  Treatment of bacterial endocarditis with cephalothin.

Authors:  J J Rahal; B R Meyers; L Weinstein
Journal:  N Engl J Med       Date:  1968-12-12       Impact factor: 91.245

3.  Cephaloridine therapy as related to renal function.

Authors:  S A Kabins; S Cohen
Journal:  Antimicrob Agents Chemother (Bethesda)       Date:  1965

4.  Cephalothin in serious bacterial infection.

Authors:  S L Merrill; A Davis; B Smolens; S M Finegold
Journal:  Ann Intern Med       Date:  1966-01       Impact factor: 25.391

5.  Excretion of cephaloridine and cephalothin in patients with renal impairment.

Authors:  C M Kunin; N Atuk
Journal:  N Engl J Med       Date:  1966-03-24       Impact factor: 91.245

  5 in total
  2 in total

1.  75Se-sodium selenite as a diagnostic aid in the assessment of peripheral pulmonary opacities.

Authors:  I D Whitton; A E Houlder
Journal:  Thorax       Date:  1979-02       Impact factor: 9.139

2.  Prophylaxis of postpneumonectomy empyema.

Authors:  P Goldstraw
Journal:  Thorax       Date:  1980-02       Impact factor: 9.139

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.